Cameroon vs Rwanda: Population requiring preventive chemotherapy for schistosomiasis
Cameroon
6.80 million
in 2024
Rwanda
5.47 million
in 2024
Cameroon rank
12th
Rwanda rank
14th
Population requiring preventive chemotherapy for schistosomiasis over time
- Cameroon
- Rwanda
How they compare
Cameroon currently reports 6.80 million against 5.47 million in Rwanda, a difference of 1.33 million.
That makes Cameroon's figure about 1.2 times Rwanda's.
Across all 15 years both countries report, Cameroon has been ahead every year.
Cameroon ranks 12th and Rwanda ranks 14th of 52 countries.
Cameroon has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Cameroon | Rwanda | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 6.46 million | 1.64 million | 4.82 million | Cameroon |
| 2020s | 6.02 million | 4.32 million | 1.69 million | Cameroon |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher population requiring preventive chemotherapy for schistosomiasis, Cameroon or Rwanda?
- Cameroon, at 6.80 million against 5.47 million in Rwanda as of 2024.
- What is the difference in population requiring preventive chemotherapy for schistosomiasis between Cameroon and Rwanda?
- 1.33 million, with Cameroon ahead.
- How many years of comparable data are there for Cameroon and Rwanda?
- 15 years are reported by both, from 2010 to 2024.
- How do Cameroon and Rwanda rank globally for population requiring preventive chemotherapy for schistosomiasis?
- Cameroon ranks 12th and Rwanda ranks 14th of 52 countries.
- Where does this data come from?
- Our World in Data, published as Population requiring preventive chemotherapy for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.